Barnett & Company’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-115
| Closed | -$7K | – | 113 |
|
2021
Q4 | $7K | Buy |
+115
| New | +$7K | ﹤0.01% | 209 |
|
2021
Q2 | – | Sell |
-27,500
| Closed | -$1.37M | – | 226 |
|
2021
Q1 | $1.37M | Buy |
27,500
+2,000
| +8% | +$99.4K | 0.73% | 38 |
|
2020
Q4 | $1.27M | Sell |
25,500
-4,200
| -14% | -$210K | 0.8% | 34 |
|
2020
Q3 | $1.63M | Buy |
29,700
+1,500
| +5% | +$82.2K | 1.16% | 23 |
|
2020
Q2 | $1.49M | Buy |
+28,200
| New | +$1.49M | 1.21% | 22 |
|
2017
Q4 | – | Sell |
-162
| Closed | -$5K | – | 317 |
|
2017
Q3 | $5K | Hold |
162
| – | – | ﹤0.01% | 303 |
|
2017
Q2 | $6K | Hold |
162
| – | – | ﹤0.01% | 322 |
|
2017
Q1 | $5K | Hold |
162
| – | – | ﹤0.01% | 310 |
|
2016
Q4 | $4K | Hold |
162
| – | – | ﹤0.01% | 351 |
|
2016
Q3 | $5K | Hold |
162
| – | – | ﹤0.01% | 357 |
|
2016
Q2 | $5K | Hold |
162
| – | – | ﹤0.01% | 344 |
|
2016
Q1 | $5K | Buy |
+162
| New | +$5K | ﹤0.01% | 361 |
|